Super excited about this work! We are finally able to not only screen binders for specificity, but design them to be specific 🤯 this will be transformational in the development of pMHC binders and therapeutics in general
RFD4-Proteina, co-developed by @UWproteindesign@UWMedicine & @NVIDIAHealth, debuts today at GTC Berlin. The open-source generative model will use biomolecular reasoning to find new protein solutions for medicine, sustainability, materials & biotech. https://t.co/GSy9hwvoRM
Need compute to compete in protein design competitions like this one?
https://t.co/fedrGMwq4d
RFD4-Proteina is now on Hugging Face with two weeks of NVIDIA-sponsored access. 🧵👇
It has been incredibly exciting to bring the RFdiffusion and Proteina model families together. An amazing release! 💜💚🔥🎉
And I am just as excited about the applications! 🧬
Massive congrats to @DidiKieran, @nscorley, @RafiBrent, @maxkazman and the many more contributors!
What a wild ride! After a fantastic collaboration between @UWproteindesign and Nvidia GenAIR, we've released the latest in the RFdiffusion and Proteina lineages, namely... RFD4-Proteina! Computationally and in the lab, the results have astonished us🧵 1/n https://t.co/PPddK8nlsb
What a wild ride! After a fantastic collaboration between @UWproteindesign and Nvidia GenAIR, we've released the latest in the RFdiffusion and Proteina lineages, namely... RFD4-Proteina! Computationally and in the lab, the results have astonished us🧵 1/n https://t.co/PPddK8nlsb
Great things come from great teams! Super excited to share https://t.co/TnVV8YAW3f, a step-function improvement in generative protein design! A year in the making with @UWproteindesign , NVIDIA GenAIR and the amazing @DidiKieran@nscorley and @RafiBrent! 🧵1/n
Expect more threads in the coming days -- so much to share and so many cool learnings!
Website: https://t.co/q3Qwx6kU0k
Paper: https://t.co/Lq5tP2yoVA
Code: https://t.co/lSpzSXk4Tp
Demo: https://t.co/kgTVA2NMCp
🧵n/n
🧬 Design proteins faster and send fewer, better candidates to the lab.
Introducing RFD4-Proteina, a new NVIDIA BioNeMo open model co-developed with @UWproteindesign.
▫️Fast: 13× faster generation than RFdiffusion3 at 200 residues
▫️ Smart: state-of-the-art across 12+ protein design tasks
▫️ Programmable: set your design inputs and use test-time compute on harder problems
Start with our binder-design tutorial https://t.co/fmS7miF1VD
A step change in protein design: RFD4-Proteina is enables everyone today.
We partenered with @huggingface to make available a free space.
You can solve your hardest biology problem right now. No CS degree required: https://t.co/VcYse3Ddvx
More to come...
Protein design doesn’t have to stop at the canonical 20 amino acids! After our work on phosphotyrosine binders, RFD4-Proteina adds phosphoserine and phosphothreonine (below) to the repertoire, with binders that distinguish adjacent H3pS10 and H3pT11 sites in the histone H3 tail!
@NVIDIAHealth and the Institute for Protein Design, led by Nobel laureate David Baker, just released RFD4-Proteina today at GTC Berlin, an open model that designs a protein’s sequence and structure together against a target. Apheris is a launch distribution partner. We run RFD4-Proteina on your own GPUs, inside your environment, and you can fine-tune it on your own structures and assays to design VHHs, antibodies, binders and enzymes and customize it to your chemistry.
New de novo design model from Baker Lab + NVIDIA, available on Tamarind today.
We are excited to be working with @NVIDIAHealth to bring access to RFD4-Proteina on day 0.
1/n
Crossover episode! We introduce RFD4-Proteina, our latest design model - and the result of a year-long collaboration between the Baker Lab and NVIDIA GenAIR (the name says it all…). I hope you’ll agree - the results are astonishing. 🌐 Website: https://t.co/FRbZU8OiKy
Avengers assemble: 1 year BakerLab + NVIDIA GenAIR = 🔥 https://t.co/Cd2qiugCJo
Presenting RFD4-Proteina, our latest protein design model, significantly better and faster than everything we compared against, both in silico and in the lab! 1/30